Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / Q••••••••

Q•••••••• Secures Growth Investment from E•• P••••••• to Accelerate Clinical Trial Intelligence

Growth investmentannouncedannounced May 13, 2026Fact
What happened
Target
Q••••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / clinic, pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • B•••• C••••••Deal partnerconfirmed
    “Investor Perspective "AI is fundamentally transforming clinical development, and sample and biomarker intelligence represents one of its highest-impact applications," said B•••• C••••••, Founder and Chief Executive Officer of E•• P•••••••.”
  • E•• P•••••••Sponsorconfirmed
    “Q••••••••, a life science technology company delivering portfolio‑scale sample and biomarker intelligence for clinical‑stage biopharma, today announced a strategic growth investment and controlling interest from E•• P•••••••, a private equity firm focused on health tech and tech-enabled services.”
Advisory side
  • B••••• P•••••••Sell-side adviserconfirmed
    “B••••• P••••••• served as an exclusive financial advisor to Q••••••••.”
Side not stated
  • Q••••••••Targetconfirmed
    “Q•••••••• Secures Growth Investment from E•• P••••••• to Accelerate Clinical Trial Intelligence”
Evidence
“Q•••••••• Secures Growth Investment from E•• P••••••• to Accelerate Clinical Trial Intelligence”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
Q•••••••• Secures Growth Investment from E•• P••••••• to Accelerate Clinical Trial Intelli | Private Equity Intelligence | DFX